Microbial features linked to medication strategies in cardiometabolic disease management
Researchers explored the association of microbial structure with the use of single or multiple medications among participants from Alberta’s Tomorrow Project who were diagnosed with cardiometabolic disease. Forty-six associations were identified between microbial composition and single medications. Findings indicated that both single- and multiple medication use in cardiometabolic disease is associated with decreases in bacterial diversity, species, and microbial functional potential.
Physical activity-induced alterations of the gut microbiota are BMI dependent
Researchers assessed physical activity and hand-grip strength’s role in gut microbiome composition in middle-aged adults with normal and overweight body mass index. Data from 443 participants from Alberta’s Tomorrow Project suggest that BMI plays a significant role in modelling PA-induced changes in gut microbiota.